Walgreens Boots Alliance, Inc. operates in the healthcare sector, focusing on pharmacy-led and retail operations. The company has managed to maintain a stable presence in the market, but current financial indicators suggest the need for cautious optimism moving forward. Investors are recommended to closely monitor both domestic and international growth strategies.
Walgreens Boots Alliance, Inc. has been rated with a 'C+'. The company's score indicates a struggle in maintaining consistent financial performance when compared to market standards.
Category | Score | Score Visualization |
---|---|---|
Overall Score | 2 | |
Discounted Cash Flow | 5 | |
Return on Equity | 1 | |
Return on Assets | 1 | |
Debt to Equity | 1 | |
Price to Earnings | 1 | |
Price to Book | 3 |
The historical scores reflect a consistent challenge in achieving financial improvements, with little significant change.
Date | Overall Score | DCF | ROE | ROA | Debt to Equity | P/E | P/B |
---|---|---|---|---|---|---|---|
2025-04-11 | 2 | 5 | 1 | 1 | 1 | 1 | 3 |
Previous | 0 | 5 | 1 | 1 | 1 | 1 | 3 |
The current analyst estimates suggest limited growth potential, with a consensus to hold the stock.
High | Low | Median | Consensus |
---|---|---|---|
$10 | $9 | $9 | $9.4 |
Analysts remain cautious, with recommendations predominantly leaning towards holding the stock, influenced by the current market conditions.
Recommendation | Count | Visual Representation |
---|---|---|
Strong Buy | 0 | |
Buy | 5 | |
Hold | 15 | |
Sell | 5 | |
Strong Sell | 0 |
Walgreens Boots Alliance, Inc. presents a complex investment opportunity. While the company's strong brand and expansive retail footprint provide a solid foundation, its financial performance remains under pressure. Current market conditions highlight limited upside potential as reflected in analyst ratings. Investors may want to weigh the risks associated with external market factors against potential long-term benefits. Strategic adjustments and robust management decisions could improve stock performance.